A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at least one magnesium-counter ion compound. A magnesium-counter ion composition described herein may be useful for any of a variety of application
A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at least one magnesium-counter ion compound. A magnesium-counter ion composition described herein may be useful for any of a variety of applications provided herein, such as maintaining, enhancing, and/or improving health, nutrition, and/or another condition of a subject, and/or cognitive, learning, and/or memory function. A magnesium-counter ion composition provided herein may be useful for administration to a subject presenting magnesium deficiency, mild cognitive impairment, Alzheimer's disease, attention deficit hyperactivity disorder, ALS, Parkinson's disease, diabetes, migraine, anxiety disorder, mood disorder, and/or hypertension. A kit, method, and other associated technology are also provided.
대표청구항▼
1. A food composition comprising a food carrier and magnesium threonate. 2. The food composition of claim 1, wherein said food composition is packaged as a beverage. 3. The food composition of claim 1, wherein said food composition is packaged as a solid food. 4. The food composition of claim 1, whe
1. A food composition comprising a food carrier and magnesium threonate. 2. The food composition of claim 1, wherein said food composition is packaged as a beverage. 3. The food composition of claim 1, wherein said food composition is packaged as a solid food. 4. The food composition of claim 1, wherein said food composition is packaged as semi-solid food. 5. The food composition of claim 1, wherein said food composition is packaged as a food product selected from the group consisting of a snack bar, cereal product, bakery product, and dairy product. 6. The food composition of claim 1, wherein said food carrier is milk. 7. The food composition of claim 1, wherein said food composition is a soft drink. 8. A food composition comprising: a. an effective amount of magnesium threonate for modulating cognitive function or a neurological disorder in a subject in need thereof; andb. a food carrier. 9. The food composition of claim 8 that is packaged as a beverage. 10. The food composition of claim 8 that is packaged as a solid food. 11. The food composition of claim 8 that is packaged as semi-solid food. 12. The food composition of claim 8 that is packaged as a food product selected from the group consisting of a snack bar, cereal product, bakery product, and dairy product. 13. The food composition of claim 8, wherein the magnesium threonate is present in an amount effective to enhance short-term memory or long-term memory. 14. The food composition of claim 8, wherein the magnesium threonate is present in an amount effective to ameliorate dementia. 15. The food composition of claim 8, wherein the magnesium threonate is present in an amount effective to ameliorate depression. 16. A food supplement comprising magnesium threonate and a food additive agent. 17. A method of preparing the food supplement of claim 16, comprising mixing magnesium threonate with the food additive agent. 18. The method of claim 17, wherein the food additive agent is selected from the group consisting of a sweetening agent, a flavoring agent, a coloring agent, a filling agent, a binding agent, a lubricating agent, and a preservative agent.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (11)
William T. Evans ; Dwight L. McKee, Alkali or alkaline earth metal of n-butyric acid for treatment of cognitive and emotional conditions.
George H. Clark ; Mary Ann Clark, Carbonated fortified milk-based beverage and method of making carbonated fortified milk-based beverage for the supplementation of essential nutrients in the human diet.
Yu Kai,CNX ; Wang Zhiwen,CNX ; Kou Fuping,CNX, L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof.
Skyler Jay S. (Key Biscayne FL) Frost Phillip (Miami Beach FL) Hahn Elliot F. (North Miami Beach FL), Method and composition for treatment of insulin resistance syndromes.
Glick J. Leslie (Potomac MD), Methods for diagnosing, monitoring and controlling the onset and progression of certain dementias and impeding memory lo.
Atalla Rajai H. (Verona WI) Weinstock Ira A. (Madison WI) Hill Craig L. (Atlanta GA) Reiner Richard S. (Madison WI), Oxidation of lignin and polysaccharides mediated by polyoxometalate treatment of wood pulp.
Costa Jonathan L. (Wheaton IL) Diazgranados Jesus A. (Cali COX), Treatment of human diseases involving dysregulation or dysfunction of the nervous system.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.